Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Biodel Inc.
DescriptionUltra-rapid-acting formulation of recombinant human insulin
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentPhase II
Standard IndicationDiabetes
Indication DetailsTreat Type I and II diabetes in patients with severe insulin resistance; Treat Type II diabetes
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today